1,453
Views
6
CrossRef citations to date
0
Altmetric
Article

miR-342 suppresses the proliferation and invasion of acute myeloid leukemia by targeting Naa10p

, &
Pages 3671-3676 | Received 07 Dec 2018, Accepted 16 Jan 2019, Published online: 09 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dan Xu, Jinlong Jiang, Guangsheng He, Haixia Zhou & Chengfu Ji. (2023) KMT2A is targeted by miR-361-3p and modulates leukemia cell’s abilities to proliferate, migrate and invade. Hematology 28:1.
Read now

Articles from other publishers (5)

Kuo-Hao Ho, Ke-Fan Pan, Tsu-Yao Cheng, Ming-Hsien Chien & Kuo-Tai Hua. (2023) Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:6, pages 188973.
Crossref
Argiris Symeonidis, Theodora Chatzilygeroudi, Vasiliki Chondrou & Argyro Sgourou. (2022) Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes. International Journal of Molecular Sciences 23:24, pages 16069.
Crossref
Yi-Ying Wu, Hsing-Fan Lai, Tzu-Chuan Huang, Yu-Guang Chen, Ren-Hua Ye, Ping-Ying Chang, Shiue-Wei Lai, Yeu-Chin Chen, Cho-Hao Lee, Wei-Nung Liu, Ming-Shen Dai, Jia-Hong Chen, Ching-Liang Ho & Yi-Lin Chiu. (2021) Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance. Cell Death & Disease 12:10.
Crossref
Juliana Ravelli Baldassarre Martins, Leonardo Nazario de Moraes, Sarah Santiloni Cury, Juliane Dadalto, Juliana Capannacci, Robson Francisco Carvalho, Célia Regina Nogueira, Newton Key Hokama & Paula de Oliveira Montandon Hokama. (2020) Comparison of microRNA Expression Profile in Chronic Myeloid Leukemia Patients Newly Diagnosed and Treated by Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Oncology 10.
Crossref
Mingyu Li, Xianglun Cui & Hongzai Guan. (2020) MicroRNAs: pivotal regulators in acute myeloid leukemia. Annals of Hematology 99:3, pages 399-412.
Crossref